RB

Rohan Bansal

Active Director Director DIN 06794285
DIN 06794285 First appointment Mar 2014 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2014
Shareholding value •••• Premium profile

About Rohan Bansal

Data last updated:

Rohan Bansal is a Director at Rajshree Fine Chemical Industries India Private Limited (since 2018), Director at Bansal Mega Builder Private Limited (since 2021) and Director at Rajshree Life Initiative Foundation (since 2025), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Real Estate and Construction and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹448 Cr; the largest is Rajshree Fine Chemical Industries India Private Limited at ₹448 Cr (FY 2025). Earlier, Rohan Bansal was a Director at Himank Medicos Private Limited (from 2014).

DIN 06794285
Primary Designation Director
Industry Chemicals and Materials
First Appointment 24 Mar 2014
Oldest Company Age 12 yrs
Largest company Rajshree Fine Chemical Industries India Private Limited · ₹448 Cr (FY 2025)
Combined revenue ₹448 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Oct 20182018₹448 Cr (FY 2025)Active
Bansal Mega Builder Private Limited U70109UP2021PTC145076
Director13 Apr 20212021₹17.5 Lakh (FY 2025)Active
Rajshree Life Initiative Foundation U86100UP2025NPL220011
Director29 Mar 20252025Active
Rajshree Educational Foundation U85499UP2024NPL197186
Director08 Feb 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Himank Medicos Private Limited U85100UP2014PTC063546
Director24 Mar 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rajshree Fine Chemical Industries India Private Limited
Bansal Mega Builder Private Limited
Himank Medicos Private Limited
Rajshree Life Initiative Foundation
Premium access

Shareholding and investment profile for Rohan Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohan Bansal

Rohan Bansal currently holds 4 directorships: Rajshree Fine Chemical Industries India Private Limited (Director, since 01 Oct 2018, revenue ₹448 Cr (FY 2025)); Bansal Mega Builder Private Limited (Director, since 13 Apr 2021, revenue ₹17.5 Lakh (FY 2025)); Rajshree Life Initiative Foundation (Director, since 29 Mar 2025); Rajshree Educational Foundation (Director, since 08 Feb 2024).

Rohan Bansal was first appointed on 24 Mar 2014 as Director at Himank Medicos Private Limited. The most recent appointment on record is 29 Mar 2025 at Rajshree Life Initiative Foundation.

The 2 current companies of Rohan Bansal that report revenue have a combined latest revenue of ₹448 Cr: Rajshree Fine Chemical Industries India Private Limited ₹448 Cr (FY 2025); Bansal Mega Builder Private Limited ₹17.5 Lakh (FY 2025).

Rohan Bansal held 1 earlier board appointment: Himank Medicos Private Limited (Director, from 24 Mar 2014).

The current boards of Rohan Bansal's companies include Rajendra Kumar (Rajshree Fine Chemical Industries India Private Limited), Rakesh Kumar Agarwal (Rajshree Fine Chemical Industries India Private Limited), Rishabh Bansal (Rajshree Fine Chemical Industries India Private Limited), Monika Agarwal (Rajshree Life Initiative Foundation), Tulika Agarwal (Rajshree Life Initiative Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available